Hong Kong, China

Yujuan Dong


Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2019-2021

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Yujuan Dong: Innovator in Colorectal Cancer Research

Introduction

Yujuan Dong is a prominent inventor based in Hong Kong, CN. She has made significant contributions to the field of colorectal cancer research, holding 2 patents that focus on innovative diagnostic and treatment methods.

Latest Patents

One of her latest patents is titled "miR-133a as a marker for colorectal cancer." This invention provides methods for assessing the likelihood of effectiveness of chemotherapy, such as oxaliplatin treatment, in colorectal cancer patients. It also evaluates their survival prospects by determining the level of miR-133a in cancer tissue. Additionally, a kit useful for these methods is included in the patent. Another notable patent is "Tumor suppressor VSTM2A as a biomarker for colorectal cancer." This invention offers a method for diagnosing and determining the prognosis of colorectal cancer by detecting suppressed expression of the VSTM2A gene, which may be due to elevated methylation levels in its genomic sequence. This patent also includes a kit and device useful for the method, as well as a treatment method that increases VSTM2A gene expression or activity.

Career Highlights

Yujuan Dong is affiliated with The Chinese University of Hong Kong, where she continues her research and development in cancer diagnostics and therapeutics. Her work has garnered attention for its potential impact on improving patient outcomes in colorectal cancer.

Collaborations

Yujuan collaborates with notable colleagues, including Jun Yu and Joseph Jao Yiu Sung, enhancing the research efforts in her field.

Conclusion

Yujuan Dong is a dedicated inventor whose work in colorectal cancer research is paving the way for innovative diagnostic and treatment solutions. Her contributions are vital in the ongoing fight against cancer, and her patents reflect her commitment to improving patient care.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…